Atlas Trials

Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Clinical trial NCT02122185 · COMPLETED

Trial details

NCT number
NCT02122185
Sponsor
University of Chicago
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Brenner TumorMalignant AscitesMalignant Pleural EffusionOvarian Clear Cell CystadenocarcinomaOvarian Endometrioid AdenocarcinomaOvarian Mixed Epithelial CarcinomaOvarian Serous CystadenocarcinomaOvarian Undifferentiated AdenocarcinomaRecurrent Fallopian Tube CancerRecurrent Ovarian Epithelial CancerRecurrent Ovarian Germ Cell TumorRecurrent Primary Peritoneal Cavity Cancer
Start date
2015-02-25
Primary completion
2022-10-27
Enrollment
111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.